English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[333]
News
[1476]
Articles
[64]
Editorials
[3]
Conferences
[70]
e
learning
[10]
Trial argues strongly for the development of 1st-line biomarker selected...
Prof Jennifer Knox - University of Toronto, Toronto, Canada
4 Jun 2024
Durvalumab plus bevacizumab, added to TACE, shows benefit for unresectable...
Dr Riccardo Lencioni - University of Pisa, Pisa, Italy
25 Jan 2024
Part 6: Which different PARP inhibitors are available
Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK
5 Sep 2023
Part 7: Similarities and Differences
Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK
5 Sep 2023
Part 8: How PARP inhibitors are being used now
Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK
5 Sep 2023
Part 9: What PARP inhibitors mean for the future and what to look out for
Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK
5 Sep 2023
Psilocybin-assisted psychotherapy for cancer-related anxiety and depression
Dr Moran Amit - The University of Texas MD Anderson Cancer Center, Houston, USA
23 Aug 2023
Sudan: Conflict, cancer care, and ripple effects on the region
Dr Nazik Hammad - University of Toronto, Toronto, Canada
19 Jul 2023
Geriatric oncology in resource-limited settings
Dr Enrique Soto Perez de Celis - National Institute of Medical Sciences, Mexico...
18 Jul 2023
Intra-arterial gemcitabine and IV gemcitabine/nab-paclitaxel show similar SAEs...
Dr Michael Pishvaian - Johns Hopkins Kimmel Cancer Center, Washington DC, USA
11 Jul 2023
Experiences of women caring for their husbands with cancer at the Cancer...
Mrs Patience Mbozi - Chreso University, Lusaka, Zambia
10 Jul 2023
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic...
Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City...
15 Jun 2023
<
1
2
3
4
5
...
28
>
More from
e
cancer